# Emergency Department-Initiated Medications for Alcohol Use Disorder

> **NIH NIH R01** · YALE UNIVERSITY · 2024 · $167,053

## Abstract

The objective of our study, Emergency Department-Initiated Medications for Alcohol Use Disorder
(1R01AA030568-01), is to compare outcomes among emergency department patients with alcohol use
disorder who are randomized to initiate treatment with naltrexone and gabapentin in the emergency
department with compared with those randomized to usual care. The purpose of this supplement is to support
the costs of conducting the study under IND status, including developing a 21 CFR compliant database,
external study monitoring, participant telephones and other associated costs.

## Key facts

- **NIH application ID:** 10938670
- **Project number:** 3R01AA030568-02S1
- **Recipient organization:** YALE UNIVERSITY
- **Principal Investigator:** Kathryn Hawk
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $167,053
- **Award type:** 3
- **Project period:** 2023-07-01 → 2028-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10938670

## Citation

> US National Institutes of Health, RePORTER application 10938670, Emergency Department-Initiated Medications for Alcohol Use Disorder (3R01AA030568-02S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10938670. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*